Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


ResMed returns fire with its own patent infringement suit

Thursday 18 August 2016 11:20 AM

ResMed returns fire with its own patent infringement suit against F&P Healthcare

By Jonathan Underhill

Aug. 18 (BusinessDesk) - ResMed has filed a patent infringement complaint in the Southern District of California, as well as lawsuits in Germany and New Zealand, and to the US International Trade Commission against Fisher & Paykel Healthcare just days after the Auckland-based company filed its own lawsuit against its US rival in the market for breathing masks and air flow products.

F&P Healthcare says it will "vigorously defend the recent allegations of patent infringement and declaratory judgment claims made by ResMed". The US company has also filed claims against F&P Healthcare in Germany and New Zealand.

“We believe we have good and valid defenses to the claims filed by ResMed and we will vigorously contest these claims," said chief executive Lewis Gradon. "We are also confident in our infringement and validity positions with respect to our own patents."

ResMed's legal action comes just two days after F&P Healthcare announced that it was "seeking all available remedies, including damages and injunctive relief" in its proceedings in the US District Court for the Central District of California. The lawsuit says ResMed's "AirSense 10 and AirCurve 10 range of flow generator products, ClimateLineAir heated air tubing for use with such flow generator products and Swift LT and Swift FX masks, infringe patents held by Fisher & Paykel Healthcare".

ResMed's suits relate to F&P Healthcare's Simplus full face mask, Eson nasal mask and Eson 2 nasal mask and has also asked the San Diego court "to invalidate patents that Fisher & Paykel recently asserted against ResMed, to declare that ResMed does not infringe those patents, or both."

"We remain steadfast in our commitment to defend our intellectual property wherever necessary to ensure patients receive the high-quality care they deserve," said ResMed global general counsel David Pendarvis. "We are confident that when the courts hear all the evidence, ResMed will prevail on its case and defeat any claims asserted by Fisher & Paykel."

F&P Healthcare shares fell 0.6 percent to $10.42 on the NZX and have gained 18 percent this year. ResMed shares fell 0.9 percent to US$68.48 and are up 28 percent this year.



© Scoop Media

Business Headlines | Sci-Tech Headlines


R&NTU: KiwiRail strike notices withdrawn following new offer

Strike notices on KiwiRail have been withdrawn. Rail and Maritime Transport Union General Secretary Wayne Butson says following negotiations between the RMTU and KiwiRail, a new offer from KiwiRail will be taken back to union members for ratification... More>>

Banking: Stress Tests Show Strengthening Bank Resilience

The latest stress tests carried out by the Reserve Bank of New Zealand – Te Pūtea Matua show strengthening resilience in the banking sector and the benefits of continuing to build capital buffers... More>>

Statistics: Building Activity Down In September Quarter
The volume of building activity in New Zealand fell 8.6 percent in the September 2021 quarter, compared with the June 2021 quarter, Stats NZ said today. Residential building activity fell by 6.4 percent in the September 2021 quarter, while non-residential building activity fell 12 percent... More>>

Reserve Bank: Deputy Governor Reflects On Time At RBNZ
Central bankers must continue to look forward to guard against the unpredictable, Deputy Governor Geoff Bascand says in a speech published today. Mr Bascand joined the Reserve Bank of New Zealand – Te Pūtea Matua in 2013 during the aftermath of the Global Financial Crisis... More>>

Xero: Data Reveals ICT Expenditure Key To Small Business Sales Growth
Xero, the global small business platform, today released a new report which shows New Zealand small business ICT expenditure has increased 25 percent compared to pre-pandemic levels - more than the UK (20%) and Australia... More>>

Fonterra: Lifts Forecast Farmgate Milk Price Range And Revises Earnings Guidance At First Quarter Update

Fonterra Co-operative Group today lifted its 2021/22 forecast Farmgate Milk Price range, reported a solid start to the 2022 financial year and revised its earnings guidance... More>>

Canterbury Museum: New Research - Bald Haast's Eagle Feasted On Moa Guts

New Zealand’s extinct Haast’s Eagle (Hieraaetus moorei), the largest known eagle, gulped down viscera like a vulture and may even have been bald, new research suggests... More>>